LOLLAR; John S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LOLLAR; John S..The latest application filed is for "method of administering porcine b-domainless fviii".

Company Profile

0.25.24

LOLLAR; John S. - Decatur GA
LOLLAR; John S - Decatur GA
Lollar; John S. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of Administering Porcine B-Domainless fVIII App 20170119857 - LOLLAR; John S. ; et al.	2017-05-04
Targeted Elimination Of Factor Viii Immune Cells App 20160030529 - LOLLAR; John S ; et al.	2016-02-04
Modified Factor VIII App 20150352190 - Lollar; John S.	2015-12-10
Modified factor VIII Grant 8,951,515 - Lollar February 10, 2	2015-02-10
Method of Administering Porcine B-domainless fVIII App 20140193441 - Lollar; John S. ; et al.	2014-07-10
Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use Grant 8,519,111 - Lollar August 27, 2	2013-08-27
Method of administering porcine B-domainless fVIII Grant 8,501,694 - Lollar , et al. August 6, 2	2013-08-06
Modified Factor VIII App 20130005656 - Lollar; John S.	2013-01-03
Nucleic Ac1d And Amino Ac1d Sequences Encoding High-level Expressor Factor Viii Polypeptides And Methods Of Use App 20120270266 - Lollar; John S.	2012-10-25
Method of Administering Porcine B-Domainless fVIII App 20120270788 - Lollar; John S. ; et al.	2012-10-25
Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use Grant 8,188,246 - Lollar May 29, 2	2012-05-29
Methods of administering porcine B-domainless fVIII Grant 8,101,718 - Lollar , et al. January 24, 2	2012-01-24
Nucleic Acid And Amino Acid Sequences Encoding High-level Expressor Factor Viii Polypeptides And Methods Of Use App 20110077203 - Lollar; John S.	2011-03-31
Modified Factor Viii App 20090325881 - Lollar; John S.	2009-12-31
Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use Grant 7,635,763 - Lollar December 22, 2	2009-12-22
Methods Of Administering Porcine B-domainless Fviii App 20090270329 - Lollar; John S. ; et al.	2009-10-29
Method of administering porcine B-domainless fVIII Grant 7,576,181 - Lollar , et al. August 18, 2	2009-08-18
Modified factor VIII Grant 7,560,107 - Lollar July 14, 2	2009-07-14
Method of administering porcine B-domainless fVIII App 20070173446 - Lollar; John S. ; et al.	2007-07-26
Modified Factor VIII App 20070135342 - Lollar; John S.	2007-06-14
Modified factor VIII Grant 7,122,634 - Lollar October 17, 2	2006-10-17
Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same Grant 7,033,791 - Lollar April 25, 2	2006-04-25
Modified factor VIII Grant 7,012,132 - Lollar March 14, 2	2006-03-14
Transgenic circulating endothelial cells App 20060013805 - Hebbel; Robert P. ; et al.	2006-01-19
Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes App 20050123997 - Lollar, John S.	2005-06-09
Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use App 20050118684 - Lollar, John S.	2005-06-02
Modified factor VIII App 20050079584 - Lollar, John S.	2005-04-14
Transgenic circulating endothelial cells Grant 6,852,537 - Hebbel , et al. February 8, 2	2005-02-08
Glycosylated, low antigenicity, low immunogenicity factor VIII App 20050009148 - Lollar, John S.	2005-01-13
Factor viii c2 domain variants App 20040249134 - Lollar, John S.	2004-12-09
Modified factor VIII Grant 6,770,744 - Lollar August 3, 2	2004-08-03
Glycosylated, low antigenicity low immunogenicity factor VIII Grant 6,759,216 - Lollar July 6, 2	2004-07-06
Modified factor VIII App 20030166536 - Lollar, John S.	2003-09-04
Compositions and methods for the expression of factor VIII polypeptides and uses therefor App 20030129174 - Lollar, John S. ; et al.	2003-07-10
Modified factor VIII App 20030068785 - Lollar, John S.	2003-04-10
Compositions and methods for the expression of factor VIII polypeptides and uses therefor Grant 6,517,830 - Lollar , et al. February 11, 2	2003-02-11
Modified factor VIII App 20020182670 - Lollar, John S.	2002-12-05
Modified factor VIII Grant 6,376,463 - Lollar April 23, 2	2002-04-23
Transgenic circulating endothelial cells App 20020042130 - Hebbel, Robert P. ; et al.	2002-04-11
Modified factor VIII Grant 6,180,371 - Lollar January 30, 2	2001-01-30
Modified factor VIII Grant 5,859,204 - Lollar January 12, 1	1999-01-12
Hybrid human/animal factor VIII Grant 5,744,446 - Lollar , et al. April 28, 1	1998-04-28
Hybrid human/animal factor VIII Grant 5,663,060 - Lollar , et al. September 2, 1	1997-09-02
Hybrid human/porcine factor VIII Grant 5,583,209 - Lollar , et al. December 10, 1	1996-12-10
Hybrid human/porcine factor VIII Grant 5,364,771 - Lollar , et al. November 15, 1	1994-11-15

Company Registrations

NCAGE Code	49JS0	LOLLAR JOHN S
CAGE Code	49JS0	LOLLAR, JOHN S

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.